Loading
Latest filing published 29 Jan 2024 for Longboard Pharmaceuticals, Inc., €88.7M.
No signal scores available.
Arena Pharmaceuticals Inc is a declared insider of Longboard Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 16 March 2021 to 25 January 2024, the count stands at 2 filings.
Every open-market trade on record is a sale: 1 sale worth €88.7M. Since January 2024: no purchases and 1 sale on the market.
Most recently, on 29 January 2024, the filings show an open-market sale worth €88.7M in Longboard Pharmaceuticals, Inc. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations